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Abstract
Background: Murine Leukemia Virus (MLV) assembly has been long thought to occur exclusively
at the plasma membrane. Current models of retroviral particle assembly describe the recruitment
of the host vacuolar protein sorting machinery to the cell surface to induce the budding of new
particles. Previous fluorescence microscopy study reported the vesicular traffic of the MLV
components (Gag, Env and RNA). Here, electron microscopy (EM) associated with immunolabeling
approaches were used to go deeply into the assembly of the "prototypic" MLV in chronically
infected NIH3T3 cells.
Results: Beside the virus budding events seen at the cell surface of infected cells, we observed that
intracellular budding events could also occur inside the intracellular vacuoles in which many VLPs
accumulated. EM in situ hybridization and immunolabeling analyses confirmed that these latter were
MLV particles. Similar intracellular particles were detected in cells expressing MLV Gag alone.
Compartments containing the MLV particles were identified as late endosomes using Lamp1
endosomal/lysosomal marker and BSA-gold pulse-chase experiments. In addition, infectious activity
was detected in lysates of infected cells.
Conclusion:  Altogether, our results showed that assembly of MLV could occur in part in
intracellular compartments of infected murine cells and participate in the production of infectious
viruses. These observations suggested that MLV budding could present similarities with the
particular intracellular budding of HIV in infected macrophages.
Background
Retroviruses consist of an enveloped capsid containing a
dimer of genomic RNA. Genomic RNA contains genes
encoding Gag, Gag/Pol and Env precursor proteins. The
polyprotein Gag is sufficient for driving virus particle pro-
duction by promoting assembly of immature capsid to the
cellular membrane, budding, and release of the virus par-
ticles. The standard model for retrovirus production
describes the budding of particles at the plasma mem-
brane [1]. Addressing of Gag to the plasma membrane is
promoted by the Matrix domain [2] and release of the
newly formed particles from the cellular membrane is
driven by the conserved "late domain" present in the Gag
polyprotein of all retroviruses [3]. Integrity of the L-
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domain sequences is required for the late membrane fis-
sion event and the final pinching off of the budding virus
[4-6]. In the last few years, late domain sequences were
found to direct the interaction between the Gag proteins
and some cellular factors involved in the protein sorting
process and the vesicle formation during the multivesicu-
lar bodies (MVB) biogenesis [7,8]. MVB are late endo-
somal compartments accumulating internal vesicles
produced from intracisternal invagination of the endo-
somal membrane. These internal vesicles are released
either in lysosomes to allow associated protein and lipid
degradation or in the extracellular space as exosomes for
intercellular communication [9]. Internal vesicles produc-
tion and virus budding are topologically similar processes
consisting of budding away from the cytosol. Moreover,
vacuolar protein sorting factors are involved in both
events. These observations support the hypothesis that the
virus hijacks the MVB production system to direct the
budding and the release of virus particles [10].
Recently, it was shown that HIV and MLV Gag polypro-
teins can lead to the formation of virus-like particles
(VLPs) in late endosomes [11]. Interestingly, intracellular-
formed particles are the principal source of infectious HIV
particles in infected macrophages [12]. These observa-
tions have led to the actual consideration of two pathways
for HIV production: the standard budding at the plasma
membrane and a new endosomal pathway [13]. In this
latter, the fusion of the endosomes with the plasma mem-
brane leads to virus particles release in the extracellular
space [12].
Using fluorescence microscopy, several works reported
the traffic of MLV Gag and Env proteins [11,14-16]] and
viral genomic RNA [14] in endosomes of transfected or
chronically infected cells. Here, we investigated virus
assembly in NIH3T3 cells chronically infected with the
replication-competent MLV using electron microscopy
(EM). We showed that intracellular virus budding could
arise and that numerous VLPs containing MLV genomic
RNA accumulated in the Lamp-1 positive vacuoles. The
absence of VLPs in lysosomal degradative compartments
and the detection of intracellular infectious activity sug-
gested that these intracellular virus particles could partici-
pate in the MLV infection.
Results
Intravacuolar virion-like particles in cells infected with the 
replication-competent MLV
MLV assembly was investigated by EM analysis in chroni-
cally infected NIH3T3 cells producing 105-106 FFU per ml
of cell culture supernatant. The use of chronically infected
cells precludes reinfection with virion entry and ensures
that only late phases of the viral cycle were observed. For
cell morphology analysis, the cells were included in epon
as previously described [17]. Rare budding viruses were
detected at the plasma membrane (Fig. 1A), with only two
budding events for hundred of analyzed cell-sections. In
contrast, a large amount of particles with virus-like mor-
phology were detected in intracellular vacuoles (Fig. 1B).
The average size of these particles (90 nm diameter) cor-
responds to MLV particles. Moreover, the presence of dark
electron dense ring or circle in these particles is typical of
assembled MLV particles and corresponds respectively to
immature and mature forms of capsids [18]. Noteworthy,
several intravesicular buddings were also observed (Fig.
1C), with similar frequency as that observed for the exter-
nal budding (2 events for hundreds of observed infected
cells). These results indicated that intracellular budding of
VLPs did occur in intracellular compartments of chroni-
cally infected cells.
Identification of the intracellular VLPs by EM 
immunolabeling
To further characterize intracellular VLPs in the infected
cells, we used EM approach coupled to immunolabeling
with an anti-Gag antibody on lowicryl embedded sec-
tions. To estimate the frequency and intensity of the labe-
ling on particles, we quantitated the number of labeled
particles with the associated gold dots. Particles were iden-
tified by their size (between 90 and 100 nm diameter) and
electron density criteria.
Electron microscopy analysis of VLPs assembly in vacuoles of  MLV-infected NIH3T3 cells Figure 1
Electron microscopy analysis of VLPs assembly in 
vacuoles of MLV-infected NIH3T3 cells. EM analysis of 
epon embedded NIH3T3 cells chronically infected with MLV. 
A) Virus budding at the plasma membrane. B) Numerous 
mature (arrows) and immature (arrowheads) particles inside 
the intracellular endosomes. C) Budding particle into a vacu-
ole.Retrovirology 2006, 3:12 http://www.retrovirology.com/content/3/1/12
Page 3 of 9
(page number not for citation purposes)
Due to the experimental procedure, very few extracellular
virus particles were detected (7 for hundreds of infected
cells). As expected, all were labeled for Gag antigens (Fig
2A), with an average intensity of 3,3 gold dots per virus
(Table 1). Since virus particles were all immature and
located in close vicinity of the plasma membrane, they
probably have been just released from the plasma mem-
brane.
In the cells, very few labeled-Gag localized individually at
the plasma membrane and most of the Gag proteins were
detected in the intravacuolar VLPs (Fig. 2B, C). Despite the
lower quality inherent in the immunolabeling procedure,
all these Gag-labeled particles displayed the size and elec-
tron density characteristic of MLV particles and correlated
to the VLPs observed before in epon embedded samples
(Fig. 1B). Quantification of the labeling showed that 88%
of the analyzed intravacuolar particles were labeled, with
an intensity of 4 gold dots per particle, close to the labe-
ling intensity observed for released viruses (Table 1). The
unlabeled 12% could probably correspond to cellular ves-
icles which were identified by mistake as VLPs because of
the non-optimal resolution in these assays. A weak Gag
labeling was also observed on the vacuolar delimiting
membrane (Fig. 2C), supporting our observation that the
intravacuolar particles originated from budding of the
delimiting membrane. These results indicated that intrac-
ellular VLPs observed in MLV-infected cells contained
MLV Gag proteins and then corresponded to MLV virion-
like particles.
Encapsidation of the viral RNA genome in vesicular VLPs
To go further in the analysis of the vesicular VLPs, pres-
ence of the genomic RNA was investigated by EM in situ
hybridization with a specific DIG-labeled riboprobe. One
difficulty of the labeling consists of the accessibility of the
target sequence complementary to the probe, which must
be exposed at the section surface to allow riboprobe
hybridization. Among the 62 intracellular VLPs analyzed,
27 (44%) were labeled with the antisense riboprobe,
showing that at least half of the internal VLPs contained
genomic RNA (Fig. 3A). As expected, no particle labeling
was observed with the sense riboprobe used as control
(Fig. 3B). These results clearly showed that the viral RNA
genome was packaged into the intracellular VLPs.
Characterization of the VLP-containing vacuoles
In order to characterize the compartment which included
the VLPs, immunolabeling experiments with an antibody
directed against the late endosomal/lysosomal marker
Lamp-1 were undertaken. A weak labeling was observed
along the membrane of the vacuoles containing the VLPs,
which is typical of a late endosome labeling (Fig. 4A) [12].
In addition, some VLPs present in these vacuoles also
exhibited some low labeling (Fig. 4A and 4B). We noted
that other non viral structures were labeled inside the vac-
uoles (Fig. 4A), which could correspond to the intracister-
nal vesicles of the MVB. To discriminate between late
endosomes and lysosomes, lysosomal compartments
were labeled by BSA-gold endocytosis. Infected cells were
pulsed 4 hours with conjugates of BSA and 13-nm colloi-
dal gold, chased for 20 hours to label lysosomes [19], and
prepared for EM analysis. As expected, gold-labeled BSA
exclusively accumulated in lysosomal compartments
which appeared as white electron-light vacuoles (Figures
5-A and C). Clearly, the lysosome morphology differed
Immunoelectron microscopy analysis of Gag distribution in  MLV-infected cells and progeny viruses Figure 2
Immunoelectron microscopy analysis of Gag distri-
bution in MLV-infected cells and progeny viruses. Gag 
was detected by immunogold labeling in lowicryl embedded 
sections of MLV-infected cells. A) Extracellular virus particle 
(black arrow) released from the plasma membrane (black 
arrowhead) labeled with 5 nm gold particles. B) VLPs (black 
arrows) present in intracellular vacuoles (white arrows) 
were labeled with similar intensity as extracellular viruses. C) 
Magnification of intravacuolar Gag-labeled VLPs (arrows). 
Weak labeling was also observed on the vacuolar delimiting 
membrane (arrowhead).Retrovirology 2006, 3:12 http://www.retrovirology.com/content/3/1/12
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from that of other vacuoles containing VLPs (Compare Fig
5A and 5B). More than hundred cells were analyzed and
the colocalisation of the gold-labeled BSA and the VLPs
was never observed in the same vacuole. Altogether, these
results indicated that the intracellular compartments
where the VLPs accumulated corresponded to the late
endosomes related to MVB, and that no VLPs could be
detected in lysosomes.
Search for infectious activity in the lysate of MLV-infected 
cells
Previous study reported that intracellular HIV particles in
macrophages could harbor some infectious ability [20]. In
order to test whether the intracellular MLV VLPs could
also display some infectious ability, we undertook freeze
and thaw experiments to release MLV related particles
from the chronically infected cells. After drastic washes
with cold PBS, 5 × 106 cells were lysed by several freeze-
thaw cycles followed by a sonication step to release intra-
cellular particles as described in Materials and Methods.
Cellular debris were removed by centrifugation and filtra-
tion and the clarified cell lysate was used to infect target
Dunni cells. Infectivity of intracellular particles was mon-
itored by focal immunofluorescence assay (FIA) using an
antibody specific to the MLV Env protein (Fig. 6A). As a
control of wash efficiency, the same procedure was per-
formed with the last wash supernatant of same cells left
intact. The results are presented in Figure 6. Very little
infectious activity was detected in the control assay that
might result from residual contamination with external
virus particles. However, a marked increase of the infec-
tious activity was obtained when cells were submitted to
the freeze-thaw and sonication lysis. The level of this
intracellular activity is probably underestimated since
virus particles contained in cell lysate could be damaged
by the lysis procedure. Lysate obtained from mock-
infected NIH3T3 did not show any infectious activity
(data not shown). These results indicated the presence of
intracellular infectious MLV particles in the chronically
infected cells.
Gag is sufficient to assemble vesicular VLPs
The Gag polyprotein is the basic component in the mak-
ing of virion particles at the plasma membrane. Indeed,
released VLPs can be obtained upon cellular expression of
the sole Gag polyprotein [21] or can be assembled from
purified Gag under certain conditions in vitro [22]. To
investigate whether Gag may also promote the formation
of the vesicular MLV particles, immunolabeling of Gag
protein and EM analysis were conducted in derivative
human HT1080 cells that expressed Gag/Gag-Pol alone
(HT-Fly cells). As expected, a Gag-labeling of the external
VLPs, recently detached from the plasma membrane was
detected (Fig. 7A). Interestingly, we also noted the pres-
ence of intracellular VLPs displaying similar Gag-labeling
(Fig. 7B). As observed with intravacuolar MLV particles in
infected cells (Fig. 2B), these internal VLPs were concen-
trated (with some other unidentified vesicles) in intracel-
lular compartments with a morphology that might
correspond to this of MVB. Analysis of several cell sections
revealed that Gag-VLP budded more frequently at the
plasma membrane than at intracellular membrane. These
observations differ somewhat with that observed in the
context of chronic infection where frequencies of budding
at the plasma membrane or in endosomes were similar. In
Detection of the viral RNA genome in intracellular VLPs Figure 3
Detection of the viral RNA genome in intracellular 
VLPs. The MLV genomic RNA was specifically detected by 
EM in situ hybridization and was visualized by 10 nm gold 
particles. VLPs (black arrows) inside the intracellular vacu-
oles (white arrows) were labeled (arrowheads) with the spe-
cific antisense probe (A), while no signal was detected with 
the control sense riboprobe (B).
Table 1: Quantification of anti-Capsid signal
labeled particles (%) Average labeling intensity 
(gold dots per particle)
extracellular 100 3,3 ± 1,5
intracellular 88 4,0 ± 2,5
The number of gold dots present on particles that displayed the 
typical morphology and size of virus particles was determined. Due to 
their very low abundance, only 7 external particles were analyzed, 
while a total of 52 intracellular particles were examined.Retrovirology 2006, 3:12 http://www.retrovirology.com/content/3/1/12
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conclusion, these results indicated that Gag alone was suf-
ficient to generate not only the extracellular budding but
also the formation of VLPs in intracellular compartment.
Discussion
During the last years, most of the studies of endosomal
traffic of retrovirus components were undertaken using
fluorescence microscopy. Here we decided to take advan-
tage of the high resolution of the EM to evaluate the
assembly of the replication-competent MLV in chronically
infected cells. Analysis of cellular content clearly showed
that intracellular VLPs appeared very abundant in vacu-
olar compartments. This first observation substantiates
previous study reporting VLPs in intracellular compart-
ments in MLV-infected cells [23]. Using EM immunolabe-
ling experiments, we identified them as MLV related VLPs.
Several immunofluorescence studies reported that Env
and Gag colocalized in intracellular compartments
[11,14-16] and that a viral genomic RNA pool reaches the
plasma membrane bound to Gag and Env tethered at the
cytoplasmic face of the endosomal membrane [14]. The
high resolution of the EM brings more precise results
which clearly showed that, in the context of infection, a
part of this genomic RNA pool was already encapsidated
inside the intravesicular MLV particles and likely via intra-
cellular budding events mediated by Gag. Furthermore,
since the VLP-containing vacuoles were labeled by the late
endosomal/lysosomal marker Lamp-1 and not by the
BSA-gold, these latter could be identified as late endo-
somes. These results correlate with the visualization of
MLV Gag in late endosomes by fluorescence microscopy
[11,14].
We observed infectious activity in lysates of infected cells,
indicating that infectious MLV particles were present
inside the cells. It is tempting to speculate that these infec-
tious virus particles corresponded to the MLV-VLPs we
observed in late endosomes. Existence of intraendosomal
virus budding and presence of many immature virus par-
ticles among these intracellular particles strongly sug-
gested that these virus particles came from direct budding
in the endosomal vacuoles. The frequency of intracellular
budding events appeared low (2 for hundred of analyzed
cell-sections) compared to the numerous particles accu-
mulated in endosomes. However, in agreement with these
results, Hansen et al [23] reported one intracellular VLP
budding event for 22 analyzed cell-sections of MLV chron-
ically infected cells. Similar observations were previously
reported for the well documented intracellular HIV bud-
ding in macrophages where about 100 virions per vacuole
VLP-containing vacuoles and their VLPs are positive for Lamp-1 Figure 4
VLP-containing vacuoles and their VLPs are positive for Lamp-1. Lamp1 was detected in lowicryl embedded sections 
by immunogold labeling (5nm gold particles). A) Low labeling was observed on the periphery of MLV-VLPs containing vacuoles 
and on other intravacuolar components (white arrowheads). Gold particles could sometimes be found on individual intracellu-
lar MLV-VLP (black arrowhead). B) Magnification of the boxed area in A showed a Lamp1 positive MLV-VLP.Retrovirology 2006, 3:12 http://www.retrovirology.com/content/3/1/12
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were observed with only occasional budding events. This
accumulation suggested that budding detection was prob-
ably dependent of the budding rates which drastically dif-
fers among the viruses [24,25] and which should be faster
than the rate of the particles release.
The intraendosomal budding observed in the present
study, in the context of the infection with the replication-
competent MLV, might be a common alternative process
shared by all retroviruses, since it was also documented in
HIV infected macrophages [12].
Because late endosomes/MVB are directly linked to degra-
dative pathway by fusion with lysosomal compartments,
intraendosomal virus particles could be directly routed for
degradation and not participate in virus production proc-
ess. But the absence of detectable particles or viral compo-
nents in lysosomes suggests that virus particles could
escape the degradation pathway. Then, one can speculate
that intracellular particles could be released in extracellu-
lar medium by fusion of the endosomal membrane with
the plasma membrane and participate in MLV infection,
as proposed for HIV in macrophages [12,20]. Thus, the
virus particles production might occur from two different
but non exclusive ways in MLV-infected NIH3T3 cells: the
classical budding at the plasma membrane, and the bud-
ding into MVB. These budding events were both detected
in cells expressing only Gag, suggesting the recruitment of
a similar mechanism promoted by Gag.
It is not clear what determines the incidence of intracellu-
lar versus cell surface assembly. Indeed, numerous EM
analyses performed with transfected MLV Gag or reconsti-
tuted viruses, usually in human (293T), monkey (Cos), or
hamster (BHK21) cell lines, described exclusive budding
at the plasma membrane [26-28]. At the opposite, only
two studies (ours and [23]) showed the coexistence of
intracellular and cell surface in chronically infected cells.
One possible explanation for these different results is the
experimental system : transient versus stable expression
Specific labeling of lysosomal compartments by pulses of BSA-gold Figure 5
Specific labeling of lysosomal compartments by pulses of BSA-gold. Representative pictures of infected cells incu-
bated with the BSA-gold. The BSA-gold accumulated in VLP-free lysosomes (arrowhead) (A). VLPs (large arrow) and budding 
event (little arrow) were shown in unlabeled vacuole (B). Absence of colocalization of VLP (arrow) and BSA-gold (arrowhead) 
(C).Retrovirology 2006, 3:12 http://www.retrovirology.com/content/3/1/12
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systems. The chronic phase of infection could favor the
intracellular assembly as reported by Orenstein et al who
compared HIV assembly during acute and chronic phases
of infection [29]. Nevertheless, a recent work of Sherer et
al showed that even in Gag-MLV transfected 293T and
HeLa cells, MLV-VLPs can bud both at the plasma mem-
brane and at the late endosomal membrane [11]. In addi-
tion, it cannot be excluded that the incidence of MLV
intracellular versus cell surface assembly is also largely
dependent of the cell lines as well documented in the case
of HIV. In this latter, the plasma membrane budding was
predominantly observed in T cells whereas virions accu-
mulated in MVB in macrophages (see reviews [30-32]).
Recently, the observation of HIV intraendosomal budding
and the discovery of the impact of endosomal proteins
sorting pathway in retroviral budding have lead to the
Trojan exosome hypothesis [33]. This original hypothesis
proposes that retroviruses hijack the cellular exosomal
production machinery leading to the production of exo-
some-like virus particles in the MVB and their release into
the cell culture supernatant. Our report of similar alterna-
tive of intraendosomal budding in MLV-infected cells par-
ticipates to a better understanding of the fundamental
process involved in this late phase of retroviral infection.
Moreover, MLV infection could constitute a new valuable
model to evaluate in vivo the effect of new therapeutic
agents directed against intraendosomal virus production.
Materials and methods
Cell culture and infection
NIH3T3, Dunni, and Fly (a kind gift from FL Cosset) cells
were cultured in Dulbecco's modified Eagle's medium
(DMEM) supplemented with glutamine (2 mM), penicil-
lin, streptomycin and 10% heat-inactivated fetal calf
serum at 37°C. Infections were performed with Friend-
MLV viral stocks with average titer of 5 × 105 focus-form-
ing units per ml (FFU/ml) as previously described [34].
MLV-infected NIH3T3 were maintained 1 month after
infection and considered as chronically infected.
EM and immuno-EM
For conventional EM, MLV-infected NIH3T3 cell samples
were processed and embedded in epon (Embed-812, Elec-
tron Microscopy Sciences Inc.) according to a previously
described method [17]. For immuno-EM, cells were fixed
in 2,5% formaldehyde in 0.1M phosphate-buffered saline
(PBS), pH7.4 for 90 minutes, washed in PBS + 0.05M
ammonium chloride one hour, gathered in fibrin clot,
and embedded in methacrylate resin (Lowicryl K4M, Che-
mische Werke Lowi). Ultrathin sections were cut with a
Reichert OMU2 ultramicrotome and collected with gold
grids 300 mesh. After blocking 20 minutes in Tris buffered
saline (TBS) proteined (20 mM Tris-HCl pH 8,2, 20 mM
sodium azide, 0,1% Tween 20, 1% goat serum, 1% bovine
serum albumin), immunogold labeling was performed by
incubating sections overnight at 4°C with primary anti-
body diluted in proteined TBS and one hour at room tem-
perature with diluted gold labeling secondary antibody.
Then, the grids were stained 20 minutes with 2% uranyl
acetate in water, air dried, and examined on a Hitachi
H1700 electron microscope. The following antibodies
were used: rat monoclonal anti-Gag antibody (H187, a
kind gift from B. Chesebro) or rat monoclonal anti-lamp1
antibody (clone 1D4B, a kind gift from M. Vidal) with
goat anti-rat antibody coupled to 5 nm gold particles
(British Biocell International, Cardiff, UK).
EM in situ hybridization
The Digoxigenin labeled RNA probes were prepared from
a linearized Bluescript plasmid containing a 652 bp MLV
genomic fragment (position 1181 to 1833 bp). In vitro
transcription was performed in the sense or anti-sense ori-
entation using a DIG RNA labeling kit (Roche). Digoxi-
genin labeled RNA were quantified as instructed by the
Gag alone can promote intracellular VLPs formation Figure 7
Gag alone can promote intracellular VLPs formation. 
Gag was detected by immunogold labeling in lowicryl embed-
ded sections of Fly packaging cells which expressed the Gag 
and Pol proteins only. A) Extracellular VLP (arrow) released 
from the plasma membrane (arrowhead) labeled with 5 nm 
gold particles. B) VLPs (arrows) present in intracellular vacu-
ole (arrowhead).Retrovirology 2006, 3:12 http://www.retrovirology.com/content/3/1/12
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manufacturer. After 10 minutes incubation in the pre-
hybridization buffer (4 × SSC + 50% formamide) at 37°C,
ultra-thin sections were incubated overnight at 37°C in
moist chamber in hybridization solution (1 µg/ml Dig-
labeled RNA probe in 40% formamide deionised, 10%
sulfate dextran, 1 × Denhart solution, 4× SSC, 250 µg/ml
tRNA, 250 µg/ml salmon sperm DNA). The grids were
washed 5 minutes in 2 × SSC and washed three times 5
minutes in 0,2 × SSC/60 % formamide at 37°C and twice
5 minutes in 2 × SSC at room temperature.
Immunogold detection of the Dig-labeled riboprobe was
performed using mouse anti-Dig antibody (Roche) and
goat anti-mouse antibody labeled with 10 nm colloidal
gold particle (British Biocell International, Cardiff, UK).
The procedure was the same as described above for
immuno-EM, except that the incubation with primary
antibody was 90 minutes at room temperature.
Labeling of lysosomes by BSA-gold endocytosis
Colloidal gold (13 nm) was prepared by trisodium citrate
reduction of gold chloride [35]. The colloid was adjusted
to pH 6.0 with 0,2 M K2CO3 and conjugated to sufficient
BSA to afford protection from NaCl-induced flocculation.
BSA-gold was harvested using ultracentrifugation proto-
cols which yielded monodisperse preparations free of
aggregates and unbound protein. The preparations were
dialyzed against PBS and adjusted to an A520 of 1.5 with
DMEM.
For lysosomes labeling, infected cells grown to 70% con-
fluence in 6 wells plate were starved 2 hours in DMEM.
After cells incubation at 37°C in 3 ml of DMEM contain-
ing 150 µl of BSA-gold solution for 4 hours, the cells were
washed 3 times with PBS and incubated in conjugate-free
medium for 20 hours as previously described [19], prior
to fixation and processing for EM.
Detection of intracellular infectious activity
For each experiment, 5 × 106 chronically infected cells,
producing viral supernatant with average titer of 5 × 105
FFU/ml, were washed 2 times with 10 ml of ice-cold PBS,
scraped with a rubber policeman and transferred to centri-
fuge tubes. Cells were washed 3 more times with 20 ml
cold PBS, resuspended in 100 µl of PBS and subjected to
4 freeze-thaw cycles followed by 2 times 30 sec sonication.
Total cell disruption was microscopically validated using
trypan blue staining. As a control for wash efficiency, the
same procedure was performed with the last wash of same
cells left intact. The samples (cell lysate or control) were
then centrifuged at 2400 rpm for 10 min at 4°C and the
supernatants of the centrifugation were added to 6 ml of
culture medium and filtrated (0,45µm). For infections,
serial dilutions of samples were used to infect target
Dunni cells. Infectious particles were detected and quanti-
tated by FIA, using monoclonal antibody (H48, a kind gift
from B. Chesebro) specific to Friend-MLV Env protein
[36].
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Infectivity of intracellular particles released by freeze-thaw  and sonication treatment Figure 6
Infectivity of intracellular particles released by 
freeze-thaw and sonication treatment. FIA was used to 
quantitate infectious particles present in the cell lyzed by 
freeze-thaw and sonication (cell lysate) or in the last wash of 
cells left intact (control). A) One typical FFU labeled with 
anti-Env antibody and detected in FIA. Insert: magnification of 
the boxed area showing infected (arrow) and non infected 
(arrowhead) Dunni cells. B) Results of the FIA expressed as 
the total number of infectious FFU detected in the total 
lysate of 5 × 106 cells. Lysis and infectivity experiments were 
performed at least 3 times and each infection test was per-
formed in triplicate. Bars, the standard error of the mean of 
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